Nix JS, Blakeley J, Rodriguez FJ. An update on the central nervous system manifestations of neurofibromatosis type 1. Acta Neuropathologica. 2019, Apr;139(4):625–41. https://doi.org/10.1007/s00401-019-02002-2
Google Scholar
Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO, et al. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: an international consensus recommendation. Genet in Med. 2022, Sep;24(9):1967–77. https://doi.org/10.1016/j.gim.2022.05.007
Google Scholar
Angelova-Toshkina D, Holzapfel J, Bette S, Decker J, Hellmann F, Traunwieser T, et al. NFB-03. Neurological manifestations in children and adolescents with neurofibromatosis type 1 – implications for management and surveillance. Neuro-Oncology. 2022, Jun;24(1):128–128. https://doi.org/10.1093/neuonc/noac079.467
Google Scholar
Morris SM, Gupta A, Kim S, Foraker RE, Gutmann DH, Payne PRO. Predictive modeling for clinical features associated with neurofibromatosis type 1. Neurol Clin Pract. 2021;11(6):e497–505. https://doi.org/10.1212/CPJ.0000000000001089
Google Scholar
Way GP, Allaway RJ, Bouley SJ, Fadul CE, Sanchez Y, Greene CS. A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma. BMC Genomics. 2017, Feb;18(1). https://doi.org/10.1186/s12864-017-3519-7
Google Scholar
Roche-Lima A, Roman-Santiago A, Feliu-Maldonado R, Rodriguez-Maldonado J, Nieves-Rodriguez BG, Carrasquillo-Carrion K, et al. Machine learning algorithm for predicting warfarin dose in Caribbean hispanics using pharmacogenetic data. Front Pharmacol. 2020, Jan;10. https://doi.org/10.3389/fphar.2019.01550
Ho CY, Kindler JM, Persohn S, Kralik SF, Robertson KA, Territo PR. Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data. Sci Rep. 2020, Oct;10(1). https://doi.org/10.1038/s41598-020-74920-1
Google Scholar
Artzi M, Gershov S, Ben-Sira L, Roth J, Kozyrev D, Shofty B, et al. Automatic segmentation, classification, and follow-up of optic pathway gliomas using deep learning and fuzzy c-means clustering based on MRI. Med Phys. 2020, Oct;47(11):5693–701. https://doi.org/10.1002/mp.14489
Google Scholar
Zhang JW, Chen W, Ly KI, Zhang X, Yan F, Jordan J, et al. DINs: deep interactive networks for neurofibroma segmentation in neurofibromatosis type 1 on whole-body MRI. IEEE J Biomed And Health Inf. 2022, Feb;26(2):786–97. https://doi.org/10.1109/jbhi.2021.3087735
Google Scholar
FotoFinder Systems.: FotoFinder AI Moleanalyzer pro. Available from: 2025. Accessed 27th June
Face2Gene.: Face2Gene. Available from: 2025. Accessed 27th June
Hsieh TC, Bar-Haim A, Moosa S, Ehmke N, Gripp KW, Pantel JT, et al. GestaltMatcher facilitates rare disease matching using facial phenotype descriptors. Nat Genet. 2022, Feb;54(3):349–57. https://doi.org/10.1038/s41588-021-01010-x
Google Scholar
NF simplified.: neurofibromatosis – information made simple. Available from: Accessed 27th June. 2025
Ronneberger O, Fischer P, Brox T. U-Net: convolutional networks for biomedical image segmentation. In: Medical image computing and computer-assisted intervention – MICCAI 2015. Springer International Publishing; 2015. p. 234–41. Available from:
Long J, Shelhamer E, Darrell T. Fully convolutional networks for semantic segmentation. 2015 IEEE Conference on Computer Vision and Pattern Recognition (CVPR). IEEE; 2015. Available from: https://doi.org/10.1109/CVPR.2015.7298965
Chen LC, Papandreou G, Kokkinos I, Murphy K, Yuille AL. DeepLab: semantic image segmentation with deep convolutional nets, atrous convolution, and fully connected CRFs. Ieee T Pattern Anal. 2018, Apr;40(4):834–48. https://doi.org/10.1109/tpami.2017.2699184
Google Scholar
Çiçek Ö, Abdulkadir A, Lienkamp SS, Brox T, Ronneberger O. 3D U-Net: learning dense volumetric segmentation from sparse annotation. In: Ourselin S, Joskowicz L, Sabuncu M, Unal G, Wells W, editors. Medical image computing and computer-assisted intervention – MICCAI 2016. Springer International Publishing; 2016. p. 424–32. Available from: https://doi.org/10.1007/978-3-319-46723-8_49
Google Scholar
Milletari F, Navab N, Ahmadi SA. V-Net: fully convolutional neural networks for volumetric medical image segmentation. 2016 Fourth International Conference on 3D Vision (3DV). IEEE; 2016. Available from: https://doi.org/10.1109/3DV.2016.79
Lötsch J, Kringel D, Ultsch A. Explainable artificial intelligence (XAI) in biomedicine: making AI decisions trustworthy for physicians and patients. BioMedinformatics. 2022;2(1):1–17. https://doi.org/10.3390/biomedinformatics2010001
Google Scholar
Zhang Y, Weng Y, Lund J. Applications of explainable artificial intelligence in diagnosis and surgery. Diagnostics. 2022;12(2). https://doi.org/10.3390/diagnostics12020237
Mertes S, Huber T, Weitz K, Heimerl A, André E. Ganterfactual – counterfactual explanations for medical non-experts using generative adversarial learning. Front Artif Intell. 2022;5:825565. https://doi.org/10.3389/FRAI.2022.825565
Jiang C, McKay RM, Lee SY, Romo CG, Blakeley JO, Haniffa M, et al. Cutaneous neurofibroma heterogeneity: factors that influence tumor burden in neurofibromatosis type 1. The J Invest Dermatol. 2023, Aug;143(8):1369–77. https://doi.org/10.1016/j.jid.2022.12.027
Google Scholar
Magro G, Broggi G, Angelico G, Puzzo L, Vecchio GM, Virzì V, et al. Practical approach to histological diagnosis of peripheral nerve sheath tumors: an update. Diagnostics. 2022, Jun;12(6):1463. 10.3390/diagnostics12061463
Google Scholar
Dombi E, Baldwin A, Marcus LJ, Fisher MJ, Weiss B, Kim A, et al. Activity of Selumetinib in neurofibromatosis type 1–related plexiform neurofibromas. NEJM Evid. 2016, Dec;375(26):2550–60. https://doi.org/10.1056/nejmoa1605943
Google Scholar
Gross AM, Wolters PL, Dombi E, Baldwin A, Whitcomb P, Fisher MJ, et al. Selumetinib in children with inoperable plexiform neurofibromas. NEJM Evid. 2020, Apr;382(15):1430–42. https://doi.org/10.1056/nejmoa1912735
Google Scholar
Solares I, Viñal D, Morales-Conejo M, Rodriguez-Salas N, Feliu J. Novel molecular targeted therapies for patients with neurofibromatosis type 1 with inoperable plexiform neurofibromas: a comprehensive review. ESMO Open. 2021, Aug;6(4):100223. https://doi.org/10.1016/j.esmoop.2021.100223
Armstrong AE, Belzberg AJ, Crawford JR, Hirbe AC, Wang ZJ. Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas. BMC Cancer. 2023, Jun;23(1). https://doi.org/10.1186/s12885-023-10996-y
Fisher MJ, Shih CS, Rhodes SD, Armstrong AE, Wolters PL, Dombi E, et al. Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial. Nat Med. 2021, Jan;27(1):165–73. https://doi.org/10.1038/s41591-020-01193-6
Google Scholar
Moertel CL, Hirbe AC, Shuhaiber HH, Bielamowicz K, Sidhu A, Viskochil D, et al. ReNeu: a pivotal, phase IIb trial of Mirdametinib in adults and children with symptomatic neurofibromatosis type 1-associated plexiform neurofibroma. J Clin Oncol. 2025, Feb;43(6):716–29. https://doi.org/10.1200/jco.24.01034
Google Scholar
Chen Y, Yu J, Ge S, Jia R, Song X, Wang Y, et al. An overview of optic pathway glioma with neurofibromatosis type 1: pathogenesis, risk factors, and therapeutic strategies. Invest Ophthalmol Visual Sci. 2024, Jun;65(6):8. https://doi.org/10.1167/iovs.65.6.8
Google Scholar
Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N, et al. Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. The Lancet Oncol. 2019, Jul;20(7):1011–22. https://doi.org/10.1016/s1470-2045(19)30277-3
Google Scholar
Widemann BC, Lu Y, Reinke D, Okuno SH, Meyer CF, Cote GM, et al. Targeting sporadic and neurofibromatosis type 1 (NF1) related refractory malignant peripheral nerve sheath tumors (MPNST) in a phase II study of Everolimus in combination with Bevacizumab (SARC016). Sarcoma. 2019; 2019, Jul.1–8. https://doi.org/10.1155/2019/7656747
Kim A, Lu Y, Okuno SH, Reinke D, Maertens O, Perentesis J, et al. Targeting refractory sarcomas and malignant peripheral nerve sheath tumors in a phase I/II study of sirolimus in combination with ganetespib (SARC023). Sarcoma. 2020; 2020, Jan.1–8. https://doi.org/10.1155/2020/5784876
Lucas CHG, Sloan EA, Gupta R, Wu J, Pratt D, Vasudevan HN, et al. Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. Acta Neuropathologica. 2022, Aug;144(4):747–65. https://doi.org/10.1007/s00401-022-02478-5
Google Scholar
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-Oncology. 2021, Jun;23(8):1231–51. https://doi.org/10.1093/neuonc/noab106
Google Scholar
Zahid S, Bashir F, Minhas K, Hilal K, Mushtaq N. Case of embryonal tumor multilayered rosettes in a patient with neurofibromatosis type 1. Child’s Nerv System. 2024, May;40(8):2625–30. https://doi.org/10.1007/s00381-024-06442-4
Google Scholar
Romo CG, Piotrowski AF, Campian JL, Diarte J, Rodriguez FJ, Bale TA, et al. Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1. Neuro-Oncology. 2023, Feb;25(8):1474–86. https://doi.org/10.1093/neuonc/noad033
Google Scholar
Fisher MJ, Jones DTW, Li Y, Guo X, Sonawane PS, Waanders AJ, et al. Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1). Acta Neuropathologica. 2021, Feb;141(4):605–17. https://doi.org/10.1007/s00401-021-02276-5
Google Scholar
Scheer M, Leisz S, Sorge E, Storozhuk O, Prell J, Ho I, et al. Neurofibromatosis type 1 gene alterations define specific features of a subset of glioblastomas. Int J Mol Sci. 2021, Dec;23(1):352. https://doi.org/10.3390/ijms23010352
Google Scholar
Banerji S, Mitra S. Deep learning in histopathology: a review. WIREs Data Min Knowl Discov. 2021, Nov;12(1). https://doi.org/10.1002/widm.1439
Hewitt KJ, Löffler CML, Muti HS, Berghoff AS, Eisenlöffel C, van Treeck M, et al. Direct image to subtype prediction for brain tumors using deep learning. Neurooncol Adv. 2023, Jan;5(1). https://doi.org/10.1093/noajnl/vdad139
Sehring J, Dohmen H, Selignow C, Schmid K, Grau S, Stein M, et al. Leveraging attention-based convolutional neural networks for meningioma classification in computational histopathology. Cancers. 2023, Oct;15(21):5190. https://doi.org/10.3390/cancers15215190
Google Scholar
Schumann Y, Dottermusch M, Schweizer L, Krech M, Lempertz T, Schüller U, et al. Morphology-based molecular classification of spinal cord ependymomas using deep neural networks. Brain Pathol. 2024, Jan. https://doi.org/10.1111/bpa.13239
Coto Hernández I, Mohan S, Jowett N. Automated stain-free histomorphometry of peripheral nerve by contrast-enhancing techniques and artificial intelligence. J Neurosci Methods. 2022, Jun;375:109598. https://doi.org/10.1016/j.jneumeth.2022.109598
Bankhead P, Loughrey MB, Fernández JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017, Dec;7(1):10.1038/s41598–017–17204–5
Google Scholar
Rigamonti A, Viatore M, Polidori R, Rahal D, Erreni M, Fumagalli MR, et al. Integrating AI-Powered digital pathology and imaging Mass cytometry identifies key classifiers of tumor cells, stroma, and immune cells in non–small cell lung cancer. Cancer Res. 2024, Feb;84(7):1165–77. https://doi.org/10.1158/0008-5472.can-23-1698
Google Scholar
Matthies L, Amir-Kabirian H, Gebrekidan MT, Braeuer AS, Speth US, Smeets R, et al. Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma. PLoS One. 2024, Apr;19(4):e0302017. https://doi.org/10.1371/journal.pone.0302017
Google Scholar
Foersch S, Glasner C, Woerl AC, Eckstein M, Wagner DC, Schulz S, et al. Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer. Nat Med. 2023, Jan;29(2):430–39. https://doi.org/10.1038/s41591-022-02134-1
Google Scholar
Way GP, Sanchez-Vega F, La K, Armenia J, Chatila WK, Luna A, et al. Machine learning detects pan-cancer ras pathway activation in the cancer genome atlas. Cell Rep. 2018, Apr;23(1):172–80.e3. https://doi.org/10.1016/j.celrep.2018.03.046
Google Scholar
Travers JG, Tomkinson J, Rubino M, Delaunay M, Bristow MR, Way GP, et al. Cell painting and machine learning distinguish fibroblasts from nonfailing and failing human hearts. Circulation. 2025, Apr;151(16):1207–10. https://doi.org/10.1161/circulationaha.124.071956
Google Scholar
Young JD, Cai C, Lu X. Unsupervised deep learning reveals prognostically relevant subtypes of glioblastoma. BMC Bioinf. 2017, Oct;18(S11). https://doi.org/10.1186/s12859-017-1798-2
Hack4Rare. 2024. Accessed 19th Feb
SYNAPSE. 2024. Accessed 19th Feb
Sundby RT, Szymanski JJ, Pan AC, Jones PA, Mahmood SZ, Reid OH, et al. Early detection of malignant and premalignant peripheral nerve tumors using cell-free DNA fragmentomics. Clin Cancer Res. 2024, Aug;30(19):4363–76. https://doi.org/10.1158/1078-0432.ccr-24-0797
Google Scholar
Manso S, Davies E, Raja M, Saveljeva S, Angulo-Herrera I, Bessler W, et al. A novel potential treatment for neurofibromatosis type 1 plexiform neurofibromas. Available from: Brussels, Belgium. Poster 127, Abstract book
Banerjee J, Allaway RJ, Taroni JN, Baker A, Zhang X, Moon CI, et al. Integrative analysis identifies candidate tumor microenvironment and intracellular signaling pathways that define tumor heterogeneity in NF1. Genes. 2020, Feb;11(2):226. https://doi.org/10.3390/genes11020226
Google Scholar
Gosline SJ. Leveraging state-of-the-art Model systems to enable AI drug response prediction algorithms in NF1 tumors. 2024 Global NF Conference. Brussels, Belgium; 2024. 20–25 June 2024. Available from: https://www.ctf.org/wp-content/uploads/2024/06/24_NFConferenceAbstractBook_web.pdf
Clayton A, DeFelice M, Zalmanek B, Hodgson J, Morin C, Simon S, et al. Centralizing neurofibromatosis experimental tool knowledge with the NF research tools database. Database. 2022 ; 2022, Jan. https://doi.org/10.1093/database/baac045
Banerjee J. Making AI/ML ready neurofibromatosis genomic datasets available through the NF Data portal, cBioportal, and other computational platforms. 2024 Global NF Conference. Brussels, Belgium;: 2024. Poster 276, Abstract book. Available from: https://www.ctf.org/wp-content/uploads/2024/06/24_NFConferenceAbstractBook_web.pdf
SYNAPSE. 2024. Accessed 19th Feb
OpenPBTA. 2024. Accessed 19th Feb
CBTN. 2024. Accessed 19th Feb
PNOC003 DIPG. 2024. Accessed 19th Feb
SYNAPSE. 2024. Accessed 19th Feb
Dong Y, Chawla NV, Swami A metapath: Scalable representation learning for heterogeneous networks. Proceedings of the 23rd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. KDD’17. ACM; 2017. Available from: https://doi.org/10.1145/3097983.3098036.2vec
SYNAPSE. 2024. Accessed 19th Feb
Liang H, Peng C, Power G, Lim J, Romo C, Fleming J, et al. Application of Artificial Intelligence in Cutaneous Neurofibroma Research: An International Collaborative Approach. Brussels, Belgium. Available from: Poster 16, Abstract book
Hellmann F, Ren Z, André E, Schuller BW. Deformable dilated faster R-CNN for universal lesion detection in CT images. 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC). IEEE; 2021. Available from: https://doi.org/10.1109/EMBC46164.2021.9631021
Carton C, Evans DG, Blanco I, Friedrich RE, Ferner RE, Farschtschi S, et al. ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1. eClinicalmedicine. 2023, Feb;56:101818. https://doi.org/10.1016/j.eclinm.2022.101818
Ahlawat S, Blakeley JO, Langmead S, Belzberg AJ, Fayad LM. Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Skeletal Radiol. 2019, Aug;49(2):199–219. https://doi.org/10.1007/s00256-019-03290-1
Google Scholar
Uthoff J, De Stefano FA, Panzer K, Darbro BW, Sato TS, Khanna R, et al. Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors. J Neuroradiol. 2019, May;46(3):179–85. https://doi.org/10.1016/j.neurad.2018.05.006
Google Scholar
Liu Y, Jordan JT, Bredella MA, Erdin S, Walker JA, Vangel M, et al. Correlation between NF1 genotype and imaging phenotype on whole-body MRI. Neurology. 2020;94(24):e2521–31. https://doi.org/10.1212/WNL.0000000000009490
Google Scholar
Hirbe AC, Gutmann DH. Neurofibromatosis type 1: a multidisciplinary approach to care. The Lancet Neurol. 2014, Aug;13(8):834–43. https://doi.org/10.1016/s1474-4422(14)70063-8
Google Scholar
Avula S, Peet A, Morana G, Morgan P, Warmuth-Metz M, Jaspan T. European society for paediatric oncology (SIOPE) MRI guidelines for imaging patients with central nervous system tumours. Child’s Nerv System. 2021, May;37(8):2497–508. https://doi.org/10.1007/s00381-021-05199-4
Google Scholar
Fangusaro J, Witt O, Hernáiz Driever P, Bag AK, de Blank P, Kadom N, et al. Response assessment in paediatric low-grade glioma: recommendations from the response assessment in pediatric neuro-oncology (RAPNO) working group. The Lancet Oncol. 2020, Jun;21(6):e305–16. https://doi.org/10.1016/s1470-2045(20)30064-4
Google Scholar
Weizman L, Ben-Sira L, Joskowicz L, Precel R, Constantini S, Ben-Bashat D. Automatic segmentation and components classification of optic pathway gliomas in MRI. In: Lecture notes in computer science. Berlin Heidelberg: Springer; 2010. p. 103–10. Available from:
Nalepa J, Adamski S, Kotowski K, Chelstowska S, Machnikowska-Sokolowska M, Bozek O, et al. Segmenting pediatric optic pathway gliomas from MRI using deep learning. Comput Biol Med. 2022, Mar;142:105237. https://doi.org/10.1016/j.compbiomed.2022.105237
Hope4Kids.: NF1 – Hope4Kids. Available from: 2025. Accessed 27th June
Solomon J, Warren K, Dombi E, Patronas N, Widemann B. Automated detection and volume measurement of plexiform neurofibromas in neurofibromatosis 1 using magnetic resonance imaging. Computerized Med Imag Graphics. 2004, Jul;28(5):257–65. https://doi.org/10.1016/j.compmedimag.2004.03.002
Google Scholar
Zhang M, Tong E, Hamrick F, Lee EH, Tam LT, Pendleton C, et al. Machine-learning approach to differentiation of benign and malignant peripheral nerve sheath tumors: a multicenter study. Neurosurgery. 2021, Jun;89(3):509–17. https://doi.org/10.1093/neuros/nyab212
Google Scholar
Ristow I, Madesta F, Well L, Shenas F, Wright F, Molwitz I, et al. Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1. Neuro-Oncology. 2022, Apr;24(10):1790–98. https://doi.org/10.1093/neuonc/noac100
Google Scholar
Wasa J, Nishida Y, Tsukushi S, Shido Y, Sugiura H, Nakashima H, et al. MRI features in the differentiation of malignant peripheral nerve sheath tumors and Neurofibromas. Am J Roentgenol. 2010, Jun;194(6):1568–74. https://doi.org/10.2214/ajr.09.2724
Google Scholar
Martin E, Geitenbeek RTJ, Coert JH, Hanff DF, Graven LH, Grünhagen DJ, et al. A Bayesian approach for diagnostic accuracy of malignant peripheral nerve sheath tumors: a systematic review and meta-analysis. Neuro-Oncology. 2020, Dec;23(4):557–71. https://doi.org/10.1093/neuonc/noaa280
Google Scholar
Vershinina O, Turubanova V, Krivonosov M, Trukhanov A, Ivanchenko M. Explainable machine learning models for glioma subtype classification and survival prediction. bioRxiv. 2025 Jun;https://doi.org/10.1101/2025.06.24.661085
Chadha S, Sritharan DV, Hager T, D’Souza R, Aneja S. Emerging trends in artificial intelligence in neuro-oncology. Curr Oncol Rep. 2025, Jun. https://doi.org/10.1007/s11912-025-01688-w
Darbandsari A, Farahani H, Asadi M, Wiens M, Cochrane D, Khajegili Mirabadi A, et al. AI-based histopathology image analysis reveals a distinct subset of endometrial cancers. Nat Commun. 2024, Jun;15(1):10.1038/s41467–024–49017–2
Google Scholar
Xu Z, Ren F, Wang P, Cao J, Tan C, Ma D, et al. A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial. Nat Med. 2025, Jun. https://doi.org/10.1038/s41591-025-03743-2
Si S, Tüting C, Lohse S, Landfester K, Lieberwirth I, Kastritis PL, et al. Structural basis of neurofibromin tetramerization and dimer-tetramer equilibrium. bioRxiv. 2025 Feb;https://doi.org/10.1101/2025.02.13.638105
Duarte JV, Ribeiro MJ, Violante IR, Cunha G, Silva E, Castelo-Branco M. Multivariate pattern analysis reveals subtle brain anomalies relevant to the cognitive phenotype in neurofibromatosis type 1: subtle anomalies in the NF1 brain: multivariate data-driven classification approach. Hum Brain Mapp. 2012, Sep;35(1):89–106. https://doi.org/10.1002/hbm.22161
Google Scholar
Wei CJ, Yan C, Tang Y, Wang W, Gu YH, Ren JY, et al. Computed tomography–based differentiation of benign and malignant craniofacial lesions in neurofibromatosis type I patients: a machine learning approach. Front Oncol. 2020, Jul;10. https://doi.org/10.3389/fonc.2020.01192
Wei CJ, Tang Y, Sun YB, Yang TL, Yan C, Liu H, et al. A multicenter study of neurofibromatosis type 1 utilizing deep learning for whole body tumor identification. NPJ Digit Med. 2025, Jan;8(1):10.1038/s41746–025–01454–z
Google Scholar
Schaefer J, Lehne M, Schepers J, Prasser F, Thun S. The use of machine learning in rare diseases: a scoping review. Orphanet J Rare Dis. 2020, Jun;15(1). https://doi.org/10.1186/s13023-020-01424-6
Zantvoort K, Nacke B, Görlich D, Hornstein S, Jacobi C, Funk B. Estimation of minimal data sets sizes for machine learning predictions in digital mental health interventions. NPJ Digit Med. 2024, Dec;7(1). https://doi.org/10.1038/s41746-024-01360-w
Thian YL, Ng DW, Hallinan JTPD, Jagmohan P, Sia SY, Mohamed JSA, et al. Effect of training data volume on performance of convolutional neural network pneumothorax classifiers. J Digit Imag. 2022, Mar;35(4):881–92. https://doi.org/10.1007/s10278-022-00594-y
Google Scholar
Rana S, Low CE, Karthikeyan M, Koh MJA, Ngeow J, Chiang J. A systematic review of diagnostic modalities and strategies for the assessment of complications in adult patients with neurofibromatosis type 1. Cancers. 2024, Mar;16(6):1119. https://doi.org/10.3390/cancers16061119
Google Scholar
Bakker A, Dhaenens B, Heimann G, Nievo M, Ferner R, Evans GD, et al. A basket-platform trial for neurofibromatosis type 1: a potential model for rare cancer predisposition syndromes. J Clin Oncol. 2023, Jun;41(16):e22550–22550. https://doi.org/10.1200/jco.2023.41.16_suppl.e22550
Google Scholar
Allaway RJ, La Rosa S, Verma S, Mangravite L, Guinney J, Blakeley J, et al. Engaging a community to enable disease-centric data sharing with the NF data portal. Sci Data. 2019, Dec;6(1). https://doi.org/10.1038/s41597-019-0317-x
Raycheva R, Kostadinov K, Mitova E, Iskrov G, Stefanov G, Vakevainen M, et al. Landscape analysis of available European data sources amenable for machine learning and recommendations on usability for rare diseases screening. Orphanet J Rare Dis. 2024, Apr;19(1):10.1186/s13023–024–03162–5
Google Scholar
Siganporia A, Varia M, Gorimar U, Nanade A. Privacy-enhanced federated learning for rare genetic disorder classification with EHR. 2023 Global Conference on Information Technologies and Communications (GCITC). IEEE; 2023. p. 1–8. Available from: https://doi.org/10.1109/GCITC60406.2023.10426518
Kalan MM, Kpotufe S. Tight rates in supervised outlier transfer learning. arXiv. Available from: https://arxiv.org/abs/2310.04686
Finn C, Abbeel P, Levine S. Model-agnostic meta-learning for fast adaptation of deep networks. Proceedings of the 34th International Conference on Machine Learning -. 2017. p. 1126–35 Volume 70. ICML’17.JMLR.org
Akpinar MH, Sengur A, Salvi M, Seoni S, Faust O, Mir H, et al. Synthetic data generation via generative adversarial networks in healthcare: a systematic review of image- and signal-based studies. IEEE Open J Eng Med Biol. 2025;6:183–92. https://doi.org/10.1109/ojemb.2024.3508472
Google Scholar
Bauer A, Trapp S, Stenger M, Leppich R, Kounev S, Leznik M, et al.: Comprehensive exploration of synthetic data generation: a survey. arXiv. Available from: https://arxiv.org/abs/2401.02524
Khosravi B, Purkayastha S, Erickson BJ, Trivedi HM, Gichoya JW. Exploring the potential of generative artificial intelligence in medical image synthesis: opportunities, challenges, and future directions. The Lancet Digit Health. 2025 Aug 100890. https://doi.org/10.1016/j.landig.2025.100890
Chauhan C, Gullapalli RR. Ethics of AI in pathology. Am J Pathol. 2021, Oct;191(10):1673–83. https://doi.org/10.1016/j.ajpath.2021.06.011
Google Scholar
Grech VS, Lotsaris K, Touma TE, Kefala V, Rallis E. The role of artificial intelligence in identifying NF1 gene variants and improving diagnosis. Genes. 2025, May;16(5):560. https://doi.org/10.3390/genes16050560
Google Scholar
Filippi CG, Stein JM, Wang Z, Bakas S, Liu Y, Chang PD, et al. Ethical considerations and fairness in the use of artificial intelligence for neuroradiology. AJNR Am J Neuroradiol. 2023, Aug;44(11):1242–48. https://doi.org/10.3174/ajnr.a7963
Google Scholar
Voigtlaender S, Pawelczyk J, Geiger M, Vaios EJ, Karschnia P, Cudkowicz M, et al. Artificial intelligence in neurology: opportunities, challenges, and policy implications. J Neurol. 2024, Feb;271(5):2258–73. https://doi.org/10.1007/s00415-024-12220-8
Google Scholar
Bleher H, Braun M. Diffused responsibility: attributions of responsibility in the use of AI-driven clinical decision support systems. AI And Ethics. 2022, Jan;2(4):747–61. https://doi.org/10.1007/s43681-022-00135-x
Google Scholar
Blackman J, Veerapen R. On the practical, ethical, and legal necessity of clinical artificial intelligence explainability: an examination of key arguments. Bmc Med Inf Decis. 2025, Mar;25(1):10.1186/s12911–025–02891–2
Pierce RL, Van Biesen W, Van Cauwenberge D, Decruyenaere J, Sterckx S. Explainability in medicine in an era of AI-based clinical decision support systems. Front Genet. 2022, Sep.13. https://doi.org/10.3389/fgene.2022.903600
Mello MM, Char D, Xu SH. Ethical obligations to inform patients about use of AI tools. JAMA. 2025, Jul. https://doi.org/10.1001/jama.2025.11417
Amann J, Vetter D, Blomberg SN, Christensen HC, Coffee M, Gerke S, et al. To explain or not to explain?—artificial intelligence explainability in clinical decision support systems. PLoS Digit Health. 2022, Feb;1(2):e0000016. https://doi.org/10.1371/journal.pdig.0000016
Google Scholar
link